Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare reform and maintain attractive long-term returns,...
[read full story]
STAMFORD, Conn. and WESTON, Mass., Nov. 6 /PRNewswire/ -- Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare...